Literature DB >> 34183727

A control framework to optimize public health policies in the course of the COVID-19 pandemic.

Igor M L Pataro1, Juliane F Oliveira2,3, Roberto F S Andrade4,5, Mauricio L Barreto4,6, Marcus Americano da Costa7, Marcelo M Morato8, Alan A S Amad9, Pablo I P Ramos4, Felipe A C Pereira10, Mateus S Silva5, Daniel C P Jorge5.   

Abstract

The SARS-CoV-2 pandemic triggered substantial economic and social disruptions. Mitigation policies varied across countries based on resources, political conditions, and human behavior. In the absence of widespread vaccination able to induce herd immunity, strategies to coexist with the virus while minimizing risks of surges are paramount, which should work in parallel with reopening societies. To support these strategies, we present a predictive control system coupled with a nonlinear model able to optimize the level of policies to stop epidemic growth. We applied this system to study the unfolding of COVID-19 in Bahia, Brazil, also assessing the effects of varying population compliance. We show the importance of finely tuning the levels of enforced measures to achieve SARS-CoV-2 containment, with periodic interventions emerging as an optimal control strategy in the long-term.

Entities:  

Year:  2021        PMID: 34183727     DOI: 10.1038/s41598-021-92636-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  3 in total

Review 1.  Updating Clinical Practices to Promote and Protect Human Milk and Breastfeeding in a COVID-19 Era.

Authors:  Johannes B van Goudoever; Diane L Spatz; Rebecca Hoban; Dani Dumitriu; Cynthia Gyamfi-Bannerman; Monika Berns; Liz McKechnie; Riccardo Davanzo
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.569

Review 2.  Natural tannins as anti-SARS-CoV-2 compounds.

Authors:  Shao-Chun Wang; I-Wen Chou; Mien-Chie Hung
Journal:  Int J Biol Sci       Date:  2022-07-11       Impact factor: 10.750

3.  Effectiveness of feedback control and the trade-off between death by COVID-19 and costs of countermeasures.

Authors:  Akira Watanabe; Hiroyuki Matsuda
Journal:  Health Care Manag Sci       Date:  2022-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.